Streetbeat News

Stock Prices

CYCCP

MOTS

PXMD

QTTB

RANI

In Friday's intraday session, several healthcare stocks experienced significant movements. PaxMedica (PXMD) led the gainers with a 110.9% increase, while Motus GI Holdings (MOTS) saw the largest decline at 39%. Other notable movers include Q32 Bio (QTTB), Cyclacel Pharmaceuticals (CYCCP), and Rani Therapeutics Holdings (RANI) among the gainers, and Monogram Orthopaedics (MGRM) and BioSig Technologies (BSGM) among the losers.

Portfolio Pulse from Benzinga Insights

April 12, 2024 | 4:31 pm

AGX

DCFC

GTI

LICY

TOMZ

In Friday's intraday session, several industrials stocks showed significant movement. Argan (AGX) led the gainers with a 24.4% increase following their Q4 earnings release, while Tritium DCFC (DCFC) experienced the largest drop among the losers, declining by 16.5%. Other notable movers included TOMI Environmental Solutions (TOMZ), Graphjet Tech (GTI), and Li-Cycle Holdings (LICY), reflecting a mix of market reactions to various company-specific developments.

Portfolio Pulse from Benzinga Insights

April 12, 2024 | 4:30 pm

CTSH

$1000 invested in Cognizant Tech Solns (CTSH) 20 years ago would now be worth $11,552.97, showcasing an average annual return of 13.2% and outperforming the market by 5.29% on an annualized basis. CTSH's current market capitalization stands at $34.89 billion.

Portfolio Pulse from Benzinga Insights

April 12, 2024 | 4:30 pm

PCAR

PACCAR (NASDAQ:PCAR) has delivered an average annual return of 20.06% over the past 5 years, outperforming the market by 8.0% annually. With a current market capitalization of $62.28 billion, an initial investment of $1000 in PCAR 5 years ago would now be worth $2,532.69.

Portfolio Pulse from Benzinga Insights

April 12, 2024 | 4:30 pm

SPY

Fed's Goolsbee highlights Middle East instability as a significant uncertainty for the Federal Reserve, particularly concerning its impact on oil prices and gas. He notes that a negative supply shock in this context would be detrimental.

Portfolio Pulse from Benzinga Newsdesk

April 12, 2024 | 4:27 pm

ULS

UL Solutions has set its IPO price at $34 per share for 3,213,875 shares, significantly above the initial pricing of $28 per share for 33.8 million shares.

Portfolio Pulse from Benzinga Newsdesk

April 12, 2024 | 4:27 pm

GNS

Genius Group Ltd (NYSE:GNS) has launched Singapore Genius City, its first Sovereign AI Education Ecosystem, offering AI education and acceleration courses in Singapore's Central Business District and online through GeniusU. The initiative includes personalized AI Avatars and Assistants, with plans for an AI Summit and certification programs in September 2024. GNS shares rose by 0.85% to $0.4730.

Portfolio Pulse from Shivani Kumaresan

April 12, 2024 | 4:26 pm

FXI

SMH

SPY

The U.S. is facing resistance to imposing additional chip restrictions on China as the election approaches. According to Bloomberg, sources familiar with the discussions have reported pushback against further chip curbs.

Portfolio Pulse from Benzinga Newsdesk

April 12, 2024 | 4:26 pm

SPY

Fed's Goolsbee expressed concerns that if shelter inflation does not revert to pre-pandemic levels, achieving the inflation target will be challenging. This statement underscores the importance of housing costs in the broader inflationary landscape and the Fed's focus on managing these pressures to meet its goals.

Portfolio Pulse from Benzinga Newsdesk

April 12, 2024 | 4:25 pm

AMZN

GOOG

IDGT

MRVL

MSFT

SPRX

Marvell Technology Inc (NASDAQ:MRVL) is poised for significant growth with its AI accelerators for Amazon, Google, and a potential deal with Microsoft, according to analysts. Needham analyst Quinn Bolton reiterated a Buy rating with a price target of $95, highlighting Marvell's growth opportunities in custom computing, cloud optics, and more. Marvell aims for AI revenue to exceed $2.5 billion by fiscal 2026 and targets a 20% share of the Data Center TAM, expected to exceed $75 billion by 2028. The company announced major deals with Amazon and Google and is developing an AI accelerator for a potential deal with Microsoft, which could be larger than the Amazon and Google engagements combined. Rosenblatt analyst Hans Mosesmann also maintained a Buy rating with a $100 price target, noting Marvell's competitive roadmap in switching and interconnect markets. Marvell stock gained 80% in the last 12 months and can be accessed through ETFs like IDGT and SPRX.

Portfolio Pulse from Anusuya Lahiri

April 12, 2024 | 4:23 pm